SITC Cancer Immunotherapy CONNECT

SITC Statement on NIH Cuts to Indirect Costs

Browse our other events



2025 Deep Dive

A Deep Dive into What's Next for TIL or Adoptive Cell Therapy After the Iovance Approval?

March 26 | 12–2 p.m. ET | Virtual

This webinar will discuss the state of TIL therapy, the biology of TIL therapy, current approaches to develop the next generation of TIL therapies, and considerations when implementing TIL therapy in the clinic.

Register Now


2025 Deep Dive

Advanced Biomarker Development and Clinical Translation: Computational Science in Immuno-oncology

April 2, 2025 | 2–3:30 p.m. ET | Virtual

This webinar will address advances that allow for interpretation of exploratory biomarker data, when most studies are typically only powered for clinical endpoints.

Register Now


2025 ACI

2025 ACI: A Focus on Bladder & Genitourinary Cancers

April 7, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Discuss immune checkpoint inhibitor rechallenge for management of bladder and genitourinary cancers. Gain in-depth clinical education from leading experts!

Register now
2025 ACI Gastrointestinal

2025 ACI: A Focus on Gastrointestinal Cancers

April 23, 2025 | 1–5 p.m. EDT | Virtual

Discuss recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers. Improve patient outcomes with cutting-edge insights from clinical experts!

Register now
Lunit

Lunit Research Program

Exclusively for SITC Members | Applications due April 30

This Lunit research program aims to enhance studies led by SITC members by enabling the use of AI for TME profiling, including quantitative immune phenotyping (IP) via three IP classification: inflamed, excluded and desert.

Learn more
2025 ACI

2025 ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines

May 8, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines!

Register now
2025 ACI

2025 ACI: A Focus on Cellular Therapies, T Cell Engagers and TIL Therapies

June 27, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T cell engagers and TIL Therapies. 

Register now

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

On behalf of SITC, we are pleased to announce the publication of a new manuscript titled, “ ...

JITC Digest March 2025

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...

JITC Digest March 2025

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...

 Latest Discussions

  • 2025 SITC Fellowships

    Posted in: Women in SITC

    Hello, I'm excited to share with you that we recently launched the 2025 ...

  • NCI Virtual Workshop - In Vivo Engineering of Immune Cells ( IVEIC ) for Cancer ...

    3 people like this.
  • The abstract submission site is NOW OPEN for 2025 SITC Spring Scientific ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family